Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Emerging Infectious Diseases
|
July 19, 2005
Veillonella montpellierensis endocarditis
Clarisse Rovery, Anne Etienne, Cédric Foucault, et al.
American Journal of Hematology
|
April 1, 2004
Severe hemolytic anemia due to cold agglutinin complicating untreated chronic hepatitis C: efficacy and safety of anti-CD20 (rituximab) treatment
Anne Etienne, Stéphane Gayet, Florian Vidal, et al.
Cancer
|
October 20, 2010
Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine: results of a retrospective comparative study
Thomas Prebet, Anne Etienne, Raynier Devillier, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 3, 2012
Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts
Julie Gertner-Dardenne, Remy Castellano, Emilie Mamessier, et al.
Cancer
|
February 28, 2007
Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia
Anne Etienne, Benjamin Esterni, Aude Charbonnier, et al.
Leukemia & Lymphoma
|
May 16, 2012
Combination of cytarabine and topotecan in patients treated for acute myeloid leukemia with persistent disease after frontline induction
Thomas Prébet, Estelle Jean, Aurélie Autret, et al.
Blood
|
September 25, 2012
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
Norbert Vey, Jean-Henri Bourhis, Nicolas Boissel, et al.
Leukemia & Lymphoma
|
October 23, 2012
Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia
Raynier Devillier, Roberto Crocchiolo, Anne Etienne, et al.
Haematologica
|
October 8, 2008
Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia
Jean-Valère Malfuson, Anne Etienne, Pascal Turlure, et al.
Cancer Genetics and Cytogenetics
|
June 19, 2007
Rearrangements involving 12q in myeloproliferative disorders: possible role of HMGA2 and SOCS2 genes
Anne Etienne, Nadine Carbuccia, José Adélaïde, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Emerging Infectious Diseases
|
July 19, 2005
Veillonella montpellierensis endocarditis
Clarisse Rovery, Anne Etienne, Cédric Foucault, et al.
American Journal of Hematology
|
April 1, 2004
Severe hemolytic anemia due to cold agglutinin complicating untreated chronic hepatitis C: efficacy and safety of anti-CD20 (rituximab) treatment
Anne Etienne, Stéphane Gayet, Florian Vidal, et al.
Cancer
|
October 20, 2010
Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine: results of a retrospective comparative study
Thomas Prebet, Anne Etienne, Raynier Devillier, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 3, 2012
Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts
Julie Gertner-Dardenne, Remy Castellano, Emilie Mamessier, et al.
Cancer
|
February 28, 2007
Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia
Anne Etienne, Benjamin Esterni, Aude Charbonnier, et al.
Leukemia & Lymphoma
|
May 16, 2012
Combination of cytarabine and topotecan in patients treated for acute myeloid leukemia with persistent disease after frontline induction
Thomas Prébet, Estelle Jean, Aurélie Autret, et al.
Blood
|
September 25, 2012
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
Norbert Vey, Jean-Henri Bourhis, Nicolas Boissel, et al.
Leukemia & Lymphoma
|
October 23, 2012
Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia
Raynier Devillier, Roberto Crocchiolo, Anne Etienne, et al.
Haematologica
|
October 8, 2008
Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia
Jean-Valère Malfuson, Anne Etienne, Pascal Turlure, et al.
Cancer Genetics and Cytogenetics
|
June 19, 2007
Rearrangements involving 12q in myeloproliferative disorders: possible role of HMGA2 and SOCS2 genes
Anne Etienne, Nadine Carbuccia, José Adélaïde, et al.
Page
of 2